Patent · US Active

Antibodies directed against Staphylococcus aureus leukotoxins

US11578119B2 · kind B2 · utility

1Cited by

7References

20Claims

0Family size

Assignees

MedImmune Limited · US
Humabs BioMed SA · CH

Inventors

Christine Tkaczyk · Gaithersburg, US
Bret Sellman · Rochester, US
Qun Du · Gaithersburg, US
Melissa Damschroder · Gaithersburg, US
Davide Corti · Bellinzona, CH
Andrea Minola · Bellinzona, CH

Key dates

Filing date	Jun 7, 2021
Grant date	Feb 14, 2023
Priority date	—
Expiry date	Aug 3, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to leukotoxin-binding antibodies and antigen-binding fragments thereof. The antibodies and fragments can be used, for example, to detect leukotoxin and/or in methods of treating and preventing Staphylococcus aureus infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.